PT Merck Tbk (MERK.JK)
Makes prescription medicines for cancer, diabetes, and fertility disorders sold across Indonesia.
3,900.00-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+34.0%
The outlook
MERK.JK trades at 3,900 and sits well above both its 50- and 200-day moving averages, reflecting upward momentum. The stock is positioned about two-thirds of the way through its 52-week range and carries a trailing P/E of 5.9, suggesting a relatively low valuation. Analyst coverage appears thin, but the overall data leans bullish based on technical positioning.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Market cap
$1.75T
52-wk high
4,500.00
52-wk low
2,720.00
50-day avg
3,793.20
200-day avg
3,410.70
Trailing P/E
5.9